GWCC Grand Rounds

Advancing ALK Inhibition into Early-Stage NSCLC—Integrating Biomarker-Driven Therapies to Reduce Recurrence Risk Post Resection

Presenter

Alice T. Shaw, MD, PhD
Chair, Department of Medical Oncology
Chief of Strategic Partnerships 
Dana Farber Cancer Institute

Session date: 
09/19/2025 - 8:00am to 9:00am EDT
Location: 
Virtual Meeting
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
    The George Washington University School of Medicine and Health Sciences is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
  • 1.00 Completion
Please login or register to take this course.